The closing bell has rung and now it's time to take stock of the day's market action. Some companies from our global marijuana stock database (as well a newcomer to the space) did well in today's trading session. In alphabetical order, here are 5 of the biggest marijuana stock gainers in trading on Tuesday, July 18th, 2017.
In today's trading, shares of Digipath Inc. (OTC:DIGP) rose 13.00% on volume that was more than 3x the company's 30-day average volume. Last week, Digipath announced that the company received their recreational marijuana testing license and that they successfully renewed their medical marijuana license in the state of Nevada. Be sure to check out Digipath's marijuana stock profile linked above to view custom charts and more recent news from the company.
Now Read: Digipath's Chief Scientific Officer's Comments on Strain Standardization
Emerald Health Therapeutics Inc.
Shares of Emerald Health Therapeutics Inc. (TSXV:EMH)(OTC:EMHTF) gained 7.44% in today's trading on the TSX Venture. The company's OTC Markets symbol finished the session higher by 7.40% on volume that was greater than the company's 30-day average volume. The bullish action today came without any recent news from the company. Put today's move into perspective by checking out a custom stock chart within Emerald's marijuana stock profile linked above.
Now Read: Highlights from Emerald Health's Corporate Update
Intec Pharma Ltd.
In today's trading, shares of Intec Pharma Ltd. (NASDAQ:NTEC) rose 2.75% on lighter than average volume. Last week, Intec appointed a new Chief Executive Officer that has significant experience in the life sciences space. Be sure to check out Intec's marijuana stock profile linked above to view custom charts and more recent news.
Now Read: Inside Intec Pharma's Accordion Pill Technology
Invictus MD Strategies Corp.
Today marks the fifth straight day of gains in shares of Invictus MD Strategies Corp. (TSXV:IMH)(OTC:IVITF)! On the TSX Venture, shares of Invictus closed today's trading higher by 10.66%. The company's OTC Markets symbol rose 11.85% on considerably higher than average volume. Last week, the company released an update on developments at AB Laboratories, AB Ventures and changes in their management team and announced that Acreage Pharms has broken ground on phase two of their facility. Learn more about this high flying Canadian LP by checking out their marijuana stock profile linked above.
Now Read: Highlights from Invictus MD's Corporate Update
LGC Capital Ltd.
This morning, LGC Capital (TSXV:QBA) announced that the company's joint venture with AfriAg (Pty) Ltd. has signed an agreement to acquire a 60% interest in South Africa's House of Hemp. House of Hemp is the only certified cannabis growing and processing facility in South Africa. Today's news sent shares of LGC Capital surging 55.56%! We're working on a marijuana stock profile for LGC Capital as well as a South Africa news section, so check back soon or subscribe to our free email updates newsletter to find out when it becomes available.
Now Read: TSX-V Listed Company to Acquire 60% of South African Cannabis Cultivator
To learn more about any of today's marijuana stock gainers, check out their profile in our global marijuana stock database via the linked tickers above. Remember, shares of Intec Pharma can be traded commission free using the Robinhood App.
Also, be sure to subscribe to one or more of our free email newsletters so you never miss an important update. If you haven't already, connect with The Daily Marijuana Observer on Facebook, Twitter, Instagram and StockTwits.
Now Read: Today's Biggest Marijuana Stock Losers
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.